Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Shares Outstanding: 2024-2025

Historic Shares Outstanding for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $87.0 million.

  • Kura Oncology's Shares Outstanding rose 11.92% to $87.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.0 million, marking a year-over-year increase of 11.92%. This contributed to the annual value of $78.2 million for FY2024, which is N/A change from last year.
  • Kura Oncology's Shares Outstanding amounted to $87.0 million in Q3 2025, which was up 0.25% from $86.8 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Shares Outstanding peaked at $87.0 million during Q3 2025, and registered a low of $76.2 million during Q1 2024.
  • Over the past 2 years, Kura Oncology's median Shares Outstanding value was $78.2 million (recorded in 2024), while the average stood at $80.5 million.
  • Data for Kura Oncology's Shares Outstanding shows a peak YoY rose of 13.58% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Shares Outstanding (Quarterly) stood at $78.2 million in 2024, then increased by 11.92% to $87.0 million in 2025.
  • Its Shares Outstanding stands at $87.0 million for Q3 2025, versus $86.8 million for Q2 2025 and $80.8 million for Q1 2025.